QuiaPEG Pharmaceuticals AB Patents

Patent portfolio assigned to QuiaPEG Pharmaceuticals AB (verified via public assignee records). Estimated patent count: 3. Uppsala-based clinical-stage pharma (now Quia Pharma AB, Nasdaq First North: QUIA) with the Uni-Qleaver releasable-PEGylation platform. Google Patents results show patents filed by 'QuiaPEG Pharmaceuticals Ab': WO2018163131A1 (Releasable conjugates), US11357828B2 (Releasable GLP-1 conjugates), WO2019171358A1 (Releasable antibody conjugates) - has_patents true, ~3+. No named customers/licensees disclosed.